Related Experiment Video
Updated: Jan 9, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Hospital Care for Pregnant Persons With OUD Review
Joan Park1, Mishka Terplan2, Jessica Ratner1
1Division of Addiction Medicine, Johns Hopkins School of Medicine, Baltimore, Md.
Opioid use disorder (OUD) in pregnant individuals requires compassionate care. Medications for opioid use disorder (MOUD), like methadone and buprenorphine, are safe and effective during pregnancy and postpartum.
Area of Science:
- Obstetrics and Gynecology
- Addiction Medicine
- Maternal-Fetal Medicine
Background:
- Opioid use disorder (OUD) is a growing concern in pregnant populations.
- Pregnant individuals with OUD encounter significant stigma and barriers to care.
- Healthcare providers are crucial in offering non-judgmental, harm-reduction-based treatment.
Purpose of the Study:
- To emphasize the importance of screening and treating pregnant individuals for OUD.
- To highlight the safety and efficacy of medications for opioid use disorder (MOUD) during pregnancy.
- To guide healthcare providers in managing OUD throughout pregnancy and postpartum.
Main Methods:
- Screening all pregnant individuals for OUD.
- Initiating or continuing MOUD (methadone, buprenorphine) during hospitalization.
- Adjusting MOUD dosages based on increased metabolism during pregnancy.
- Managing opioid withdrawal with MOUD and adjuvant medications.
- Providing family-centered discharge planning and postpartum support.
Main Results:
- MOUD, including methadone and buprenorphine, are safe and considered gold-standard treatments for OUD in pregnancy.
- Dosage adjustments for MOUD may be necessary due to altered pharmacokinetics in pregnancy.
- Aggressive management of opioid withdrawal is essential, potentially including full agonist opioids.
- Postpartum care is critical to prevent relapse and overdose, requiring comprehensive support services.
Conclusions:
- Universal screening and treatment of OUD in pregnant individuals are recommended.
- OUD management during pregnancy requires individualized MOUD titration and withdrawal management.
- Sustained, family-centered care into the postpartum period is vital for long-term recovery and well-being.
More Related Videos
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
05:33Author Spotlight: Alleviating Nausea and Vomiting in Pregnancy with Safe and Effective Auricular Acupuncture
Published on: August 4, 2023
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview
Restorative Care
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...